NIH Record
Doug Lowy Presents His Vision During Town Hall Meeting
Press Releases
Near-atomic resolution of protein structure by electron microscopy holds promise for drug discovery
Blog
Nanoparticle Generator Slips Chemotherapy Past Cells’ Defenses
High-Magnification Microscopy to Visualize Blood Vessels in Real Time
Opportunities in Cancer Nanotechnology
Video Helps Prepare Cancer Patients to Participate in Clinical Trials
Three New Drugs Approved for Multiple Myeloma
New Drug Shows Promise for Pediatric Neuroblastoma
Antioxidants Accelerate the Growth and Invasiveness of Tumors in Mice
CRISPR: Genome Editing Comes of Age
Persistence of Mutations After Chemotherapy Linked to Poorer Outcomes in Some AML Patients
CPTAC: A Complementary Sibling of TCGA
Gene Therapy Approach for Ovarian Cancer Shows Encouraging Signs in Animal Model
Oncolytic Therapy Shows Benefit for Patients with Melanoma
Next Round of Provocative Questions Announced
Women with Dense Breasts May Not Need Additional Screening
Using Gene Expression to Diagnose Lung Cancer More Accurately
Whole Brain Radiation Worsens Cognitive Decline
Microscopy Advances Open Up New Avenues for Cancer Discovery
An Interview with Dr. Frank McCormick
Solving the RAS Problem: Turning Off a Broken Switch
FDA Approves First Therapy for High-Risk Neuroblastoma
FDA Approves First Immunotherapy for Lung Cancer
Who Will Respond to PD-1 Inhibitors? Study Provides Clues
DNA Minicircles Could Improve Cancer Detection, Study Suggests
FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer
“Flipping the Switch”: An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology Branch
FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer